<DOC>
	<DOCNO>NCT02393703</DOCNO>
	<brief_summary>The purpose study isolate analyze exosomes , tiny carrier important protein nucleic acid serve messenger system blood tissue . Blood tissue patient pancreatic cancer compare blood tissue patient noncancerous pancreatic disease . Including patient without cancer allow investigator establish `` normal '' value , currently exist . The investigator look see whether exosome activity connection disease recurrence outcomes patient . The result study basis future study explore area .</brief_summary>
	<brief_title>Interrogation Exosome-mediated Intercellular Signaling Patients With Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Pancreatic Diseases</mesh_term>
	<criteria>All patient â‰¥ 18 year age undergoing pancreaticoduodenectomy , partial complete pancreatectomy , duodenal ampullectomy presume ductal adenocarcinoma , intraductal papillary mucinous neoplasm ( IPMN ) pancreatic neuroendocrine tumor , without invasive component ; benign pancreatic disease eligible . The presence metastatic disease disease preclude resection Receipt neoadjuvant chemotherapy radiation index cancer within 6 month enrol study INR &gt; 2 Known clot factor deficiency hypercoagulable state Any patient need anticipate need full anticoagulation hospitalization resection . Receipt antiplatelet agent ( aspirin ) precede week prior resection . IPMN pancreatic neuroendocrine tumor radiographic image high suspicion invasive component Additionally , discretion operate surgeon , blood collection would lead undue morbidity , patient exclude replace</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>exosomes</keyword>
	<keyword>15-015</keyword>
</DOC>